Aktie A228760 GENOMICTREE INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Genomictree Inc.

Aktien

A228760

KR7228760005

A228760

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 17.05.2024 		% 5 Tage % 1. Jan.
20 150 KRW -1,71 % Intraday Chart für Genomictree Inc. -3,12 % -2,18 %
2023 Genomictree Inc. meldet Ergebnis für das am 31. Dezember 2022 endende Geschäftsjahr CI
2022 Genomictree Inc. (KOSDAQ:A228760) kündigt einen Aktienrückkauf im Wert von 5.000 Millionen KRW an. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Bolsa de Madrid: Drama en OpenAI, a la espera de Nvidia
Bolsa de Madrid: La ecuación se complica
Genomictree Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.
Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.
Genomictree Inc.'s Equity Buyback announced on May 17, 2022, has expired with 380,360 shares, representing 1.86% for KRW 4,984.4 million.
Tranche Update on Genomictree Inc.'s Equity Buyback Plan announced on May 17, 2022.
Genomictree Inc. announces an Equity Buyback for KRW 5,000 million worth of its shares.
Genomictree Inc. Ltd authorizes a Buyback Plan.
Genomictree Inc. announced that it has received KRW 5.00000105 billion in funding from ORION Holdings Corp.
Genomictree Inc. announced that it expects to receive KRW 5.00000105 billion in funding from ORION Holdings Corp.
Genomictree Inc. agreed to acquire 4.8% stake in optoLANE Technologies Inc for KRW 5 billion.
Genomictree Inc. announced that it has received KRW 59.9999768 billion in funding from a group of investors
Genomictree Inc. announced that it expects to receive KRW 59.9999768 billion in funding from a group of investors
Promis Diagnostics, Inc. announced that it has received $19.99999 million in funding from Genomictree Inc.
Genomictree Inc.(KOSDAQ:A228760) added to S&P Global BMI Index
Genomictree Inc. announced that it has received KRW 7 billion in funding
Genomictree Inc. announced that it expects to receive KRW 7 billion in funding
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A228760 Aktie
  4. Nachrichten Genomictree Inc.
  5. Andere Sprachen